Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
Abstract Background Total gastrectomy (TG) is a widely accepted procedure for treating gastric stump cancer (GSC). However, subtotal gastrectomy (SG) would benefit elective patients with GSC. The aim of this study was to clarify the safety and long-term prognosis of SG in treating GSC after distal g...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-020-01821-y |
_version_ | 1818029474263859200 |
---|---|
author | Fuhai Ma Yang Li Weikun Li Wenzhe Kang Hao Liu Shuai Ma Bingzhi Wang Yibin Xie Yuxin Zhong Yingtai Chen Liyan Xue Yantao Tian |
author_facet | Fuhai Ma Yang Li Weikun Li Wenzhe Kang Hao Liu Shuai Ma Bingzhi Wang Yibin Xie Yuxin Zhong Yingtai Chen Liyan Xue Yantao Tian |
author_sort | Fuhai Ma |
collection | DOAJ |
description | Abstract Background Total gastrectomy (TG) is a widely accepted procedure for treating gastric stump cancer (GSC). However, subtotal gastrectomy (SG) would benefit elective patients with GSC. The aim of this study was to clarify the safety and long-term prognosis of SG in treating GSC after distal gastrectomy for benign lesions. Methods A total of 53 patients with GSC located at the anastomotic site or gastric body between May 1999 and December 2018 at our hospital were included. In total, 21 patients underwent SG, and the remaining 24 patients underwent TG. Clinicopathological data, operative data, and overall survival (OS) were compared. Results The operative duration, estimated blood loss volume, and length of hospital stay were similar between the SG and TG groups. The postoperative complications were similar between the two groups, but no cases of anastomotic leakage were noted in the SG group. TG was associated with significantly more retrieved lymph nodes than SG (18.5 ± 11.5 vs. 10.7 ± 9.2; p = 0.017), while the number of metastatic lymph nodes did not differ between the groups (2.9 ± 3.5 vs. 1.9 ± 3.6; p = 0.329). The median survival time in the SG group was 81.0 months (95% confidence interval (CI), 68.906 to 93.094 months), which was similar to the 45.0 months (95% CI, 15.920 to 74.080 months) observed in the TG group (p = 0.236). Both univariate and multivariate analyses showed that tumor location and histological type were prognostic factors, while surgery type was not a prognostic factor. Further stratified analyses according to tumor location revealed that OS was not significantly different between the two groups among patients with tumors located at the anastomotic site, while OS in the TG group was significantly better than that in the SG group among patients with tumors located in the gastric body (p = 0.046). Conclusions The results of the current study indicate that SG is a suitable alternative surgical procedure for GSC located at the anastomotic site after distal gastrectomy for benign lesions. The short-term outcomes and long-term prognoses of SG are comparable with those of TG. |
first_indexed | 2024-12-10T05:20:16Z |
format | Article |
id | doaj.art-458f882fb54a49dcbda4928ce58fceb4 |
institution | Directory Open Access Journal |
issn | 1477-7819 |
language | English |
last_indexed | 2024-12-10T05:20:16Z |
publishDate | 2020-02-01 |
publisher | BMC |
record_format | Article |
series | World Journal of Surgical Oncology |
spelling | doaj.art-458f882fb54a49dcbda4928ce58fceb42022-12-22T02:00:50ZengBMCWorld Journal of Surgical Oncology1477-78192020-02-011811810.1186/s12957-020-01821-yIs subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?Fuhai Ma0Yang Li1Weikun Li2Wenzhe Kang3Hao Liu4Shuai Ma5Bingzhi Wang6Yibin Xie7Yuxin Zhong8Yingtai Chen9Liyan Xue10Yantao Tian11Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Background Total gastrectomy (TG) is a widely accepted procedure for treating gastric stump cancer (GSC). However, subtotal gastrectomy (SG) would benefit elective patients with GSC. The aim of this study was to clarify the safety and long-term prognosis of SG in treating GSC after distal gastrectomy for benign lesions. Methods A total of 53 patients with GSC located at the anastomotic site or gastric body between May 1999 and December 2018 at our hospital were included. In total, 21 patients underwent SG, and the remaining 24 patients underwent TG. Clinicopathological data, operative data, and overall survival (OS) were compared. Results The operative duration, estimated blood loss volume, and length of hospital stay were similar between the SG and TG groups. The postoperative complications were similar between the two groups, but no cases of anastomotic leakage were noted in the SG group. TG was associated with significantly more retrieved lymph nodes than SG (18.5 ± 11.5 vs. 10.7 ± 9.2; p = 0.017), while the number of metastatic lymph nodes did not differ between the groups (2.9 ± 3.5 vs. 1.9 ± 3.6; p = 0.329). The median survival time in the SG group was 81.0 months (95% confidence interval (CI), 68.906 to 93.094 months), which was similar to the 45.0 months (95% CI, 15.920 to 74.080 months) observed in the TG group (p = 0.236). Both univariate and multivariate analyses showed that tumor location and histological type were prognostic factors, while surgery type was not a prognostic factor. Further stratified analyses according to tumor location revealed that OS was not significantly different between the two groups among patients with tumors located at the anastomotic site, while OS in the TG group was significantly better than that in the SG group among patients with tumors located in the gastric body (p = 0.046). Conclusions The results of the current study indicate that SG is a suitable alternative surgical procedure for GSC located at the anastomotic site after distal gastrectomy for benign lesions. The short-term outcomes and long-term prognoses of SG are comparable with those of TG.http://link.springer.com/article/10.1186/s12957-020-01821-yGastric stump cancerAnastomotic siteSubtotal gastrectomyTotal gastrectomy |
spellingShingle | Fuhai Ma Yang Li Weikun Li Wenzhe Kang Hao Liu Shuai Ma Bingzhi Wang Yibin Xie Yuxin Zhong Yingtai Chen Liyan Xue Yantao Tian Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions? World Journal of Surgical Oncology Gastric stump cancer Anastomotic site Subtotal gastrectomy Total gastrectomy |
title | Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions? |
title_full | Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions? |
title_fullStr | Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions? |
title_full_unstemmed | Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions? |
title_short | Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions? |
title_sort | is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions |
topic | Gastric stump cancer Anastomotic site Subtotal gastrectomy Total gastrectomy |
url | http://link.springer.com/article/10.1186/s12957-020-01821-y |
work_keys_str_mv | AT fuhaima issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT yangli issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT weikunli issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT wenzhekang issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT haoliu issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT shuaima issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT bingzhiwang issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT yibinxie issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT yuxinzhong issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT yingtaichen issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT liyanxue issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions AT yantaotian issubtotalgastrectomyfeasibleforthetreatmentofgastricstumpcancerlocatedattheanastomoticsiteafterdistalgastrectomyforbenignlesions |